Benjamin J Ansell

Title(s)HS Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016 Jan; 13(1):48-60. Rosenson RS, Brewer HB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR. PMID: 26323267; PMCID: PMC6245940.
      View in: PubMed   Mentions: 274     Fields:    Translation:HumansCells
    2. JCL roundtable: HDL in the primary care setting. J Clin Lipidol. 2014 Jul-Aug; 8(4):364-72. Brown WV, Ansell BJ, Mackey RH, Toth PP. PMID: 25110217.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    3. Clinical decisions. The guidelines battle on starting statins. N Engl J Med. 2014 Apr 24; 370(17):1652-8. D'Agostino RB, Ansell BJ, Mora S, Krumholz HM. PMID: 24758622.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    4. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges. Circulation. 2013 Sep 10; 128(11):1256-67. Rosenson RS, Brewer HB, Ansell B, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR. PMID: 24019446.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    5. Neisseria lactamica arthritis and septicemia complicating myeloma. J Clin Microbiol. 2010 Jun; 48(6):2318. Everts RJ, Speers D, George ST, Ansell BJ, Karunajeewa H, Ramos RD. PMID: 20410341; PMCID: PMC2884484.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    6. A review of trials evaluating nonstatin lipid-lowering therapies. Curr Atheroscler Rep. 2009 Jan; 11(1):64-6. Ansell BJ. PMID: 19080730.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2008; 10(4):213. Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M. PMID: 18828865; PMCID: PMC2575639.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    8. Hyperlipidaemia and cardiovascular disease. Curr Opin Lipidol. 2008 Aug; 19(4):433-4. Ansell BJ. PMID: 18607193.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Not getting to goal: the clinical costs of noncompliance. J Manag Care Pharm. 2008 Jul; 14(6 Suppl B):9-15. Ansell BJ. PMID: 18693783; PMCID: PMC10438241.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Targeting the anti-inflammatory effects of high-density lipoprotein. Am J Cardiol. 2007 Dec 03; 100(11 A):n3-9. Ansell BJ. PMID: 18047850.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    11. The two faces of the 'good' cholesterol. Cleve Clin J Med. 2007 Oct; 74(10):697-700, 703-5. Ansell BJ. PMID: 17941290.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. High-density lipoprotein as a therapeutic target: a systematic review. JAMA. 2007 Aug 15; 298(7):786-98. Singh IM, Shishehbor MH, Ansell BJ. PMID: 17699012.
      View in: PubMed   Mentions: 134     Fields:    Translation:HumansCells
    13. The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol. 2007 Aug; 18(4):427-34. Ansell BJ, Fonarow GC, Fogelman AM. PMID: 17620860.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    14. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. J Rheumatol. 2007 Jul; 34(7):1459-64. Charles-Schoeman C, Khanna D, Furst DE, McMahon M, Reddy ST, Fogelman AM, Paulus HE, Park GS, Gong T, Ansell BJ. PMID: 17552046.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    15. Modifying the anti-inflammatory effects of high-density lipoprotein. Curr Atheroscler Rep. 2007 Jan; 9(1):57-63. Ansell BJ, Fonarow GC, Navab M, Fogelman AM. PMID: 17169248.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    16. HDL function as a target of lipid-modifying therapy. Rev Cardiovasc Med. 2007; 8(1):1-8. Watson KE, Ansell BJ, Watson AD, Fonarow GC. PMID: 17401296.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. The potential for CETP inhibition to reduce cardiovascular disease risk. Curr Med Res Opin. 2006 Dec; 22(12):2467-78. Ansell B, Hobbs FD. PMID: 17257461.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    18. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Am Heart J. 2006 Nov; 152(5):976-81. Ansell BJ, Fonarow GC, Maki KC, Dicklin MR, Bell M, Davidson MH, NEPTUNE II Steering Committee. PMID: 17070174.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    19. High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep. 2006 Sep; 8(5):405-11. Ansell BJ, Fonarow GC, Fogelman AM. PMID: 16901411.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    20. Mechanisms of disease: proatherogenic HDL--an evolving field. Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):504-11. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. PMID: 16957764.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimals
    21. High-density lipoprotein function recent advances. J Am Coll Cardiol. 2005 Nov 15; 46(10):1792-8. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. PMID: 16286161.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    22. Evidence for a combined approach to the management of hypertension and dyslipidemia. Am J Hypertens. 2005 Sep; 18(9 Pt 1):1249-57. Ansell BJ. PMID: 16245413.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol. 2005 Aug 15; 96(4):556-63. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. PMID: 16098311.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    24. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1325-31. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, Fogelman AM. PMID: 15831812.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansAnimalsCells
    25. Rationale for combination therapy with statin drugs in the treatment of dyslipidemia. Curr Atheroscler Rep. 2005 Feb; 7(1):29-33. Ansell BJ. PMID: 15683599.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. The double jeopardy of HDL. Ann Med. 2005; 37(3):173-8. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM. PMID: 16019715.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    27. Anti-inflammatory properties of HDL. Rev Endocr Metab Disord. 2004 Dec; 5(4):351-8. Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. PMID: 15486468.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    28. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004 Jun; 45(6):993-1007. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. PMID: 15060092.
      View in: PubMed   Mentions: 202     Fields:    Translation:HumansAnimalsCells
    29. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003 Dec 02; 108(22):2751-6. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. PMID: 14638544.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansCellsCTClinical Trials
    30. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation. Heart Dis. 2003 Jan-Feb; 5(1):2-7. Ansell BJ, Watson KE, Weiss RE, Fonarow GC. PMID: 12549983.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    31. Improvement in current approaches to lipid lowering. Am Fam Physician. 2002 Mar 01; 65(5):783, 786-7. Ansell BJ. PMID: 11898952.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program. JAMA. 1999 Dec 01; 282(21):2051-7. Ansell BJ, Watson KE, Fogelman AM. PMID: 10591388.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Benjamin's Networks
    Concepts (134)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California